Neuroprotective effects of orientin on hydrogen peroxide‑induced apoptosis in SH‑SY5Y cells

Benjamin Ngee Tiing Law1, Anna Pick Kiong Ling2, Rhun Yian Koh2

  • 1School of Medical Sciences, Faculty of Medicine and Health, International Medical University, Kuala Lumpur 57000, Malaysia.

Molecular Medicine Reports
|December 25, 2013
PubMed

Insights

Orientin, a flavonoid, offers neuroprotection against oxidative stress by reducing apoptosis and modulating caspase activity in SH-SY5Y cells. This suggests potential therapeutic benefits for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Neurodegenerative diseases pose a significant challenge to aging populations globally.
  • Oxidative stress is a key pathogenic mechanism implicated in neurodegeneration.
  • Flavonoids, such as orientin, show promise as antioxidants for therapeutic intervention.

Purpose of the Study:

  • To investigate the neuroprotective effects of orientin against oxidative stress in SH-SY5Y neuroblastoma cells.
  • To determine the maximum non-toxic dose (MNTD) of orientin.
  • To evaluate orientin's impact on cell cycle, reactive oxygen species (ROS) levels, and caspase activity.

Main Methods:

  • Determined MNTD of orientin using MTT assay on SH-SY5Y cells.
  • Assessed cell cycle progression and ROS levels via flow cytometry and DCFH-DA assay.
  • Measured caspase 3/7, 8, and 9 activity using assay kits after hydrogen peroxide exposure.

Main Results:

  • Orientin (≤20 µM) exhibited no cytotoxicity to SH-SY5Y cells.
  • Orientin treatment significantly reduced the percentage of apoptotic cells induced by hydrogen peroxide.
  • Orientin inhibited caspase 3/7 activity and inactivated caspase 9 at the MNTD, without reducing ROS levels.

Conclusions:

  • Orientin demonstrates significant neuroprotective effects against oxidative stress in vitro.
  • The neuroprotection is mediated through the intracellular modulation of caspase activity.
  • Orientin holds potential as a therapeutic agent for neurodegenerative conditions.